Total Payments
$446.71
2024 Payments
$124.57
Companies
9
Transactions
11
Medicare Patients
1,875
Medicare Billing
$258,959
Payment Breakdown by Category
Food & Beverage$446.71 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $446.71 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $110.28 | 1 | $0 (2017) |
| ABIOMED | $87.92 | 1 | $0 (2024) |
| Celgene Corporation | $68.95 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $62.59 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $32.38 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $29.94 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $19.15 | 1 | $0 (2024) |
| Amgen Inc. | $18.00 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $17.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.57 | 3 | ABIOMED ($87.92) |
| 2023 | $79.35 | 2 | Gilead Sciences, Inc. ($62.59) |
| 2022 | $32.38 | 2 | Novartis Pharmaceuticals Corporation ($32.38) |
| 2021 | $18.00 | 1 | Amgen Inc. ($18.00) |
| 2020 | $13.18 | 1 | Janssen Biotech, Inc. ($13.18) |
| 2017 | $179.23 | 2 | PFIZER INC. ($110.28) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $87.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $62.59 | General |
| Category: ONC | ||||||
| 05/05/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 11/16/2020 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Oncology | ||||||
| 11/16/2017 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $110.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/20/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $68.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 177 | 371 | $165,567 | $30,691 |
| 2022 | 5 | 419 | 783 | $357,348 | $57,968 |
| 2021 | 5 | 607 | 1,072 | $103,300 | $79,277 |
| 2020 | 7 | 672 | 1,150 | $135,460 | $91,022 |
Total Patients
1,875
Total Services
3,376
Medicare Billing
$258,959
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 155 | $77,496 | $14,454 | 18.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 154 | $48,025 | $9,619 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 40 | $18,064 | $3,604 | 20.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $21,982 | $3,014 | 13.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 163 | 389 | $185,533 | $31,085 | 16.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 125 | 263 | $94,148 | $14,725 | 15.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 95 | 95 | $48,962 | $7,727 | 15.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $24,576 | $3,759 | 15.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $4,129 | $671.69 | 16.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 213 | 459 | $48,330 | $37,435 | 77.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 177 | 392 | $28,633 | $22,238 | 77.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 172 | 176 | $18,940 | $14,516 | 76.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 27 | $6,113 | $4,031 | 65.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 18 | 18 | $1,283 | $1,057 | 82.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 206 | 431 | $52,245 | $36,276 | 69.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 183 | 430 | $36,334 | $24,951 | 68.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 150 | 156 | $18,364 | $13,265 | 72.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 76 | 76 | $20,929 | $12,050 | 57.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 14 | 14 | $3,162 | $2,040 | 64.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 24 | 24 | $2,177 | $1,329 | 61.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 19 | $2,249 | $1,111 | 49.4% |
About Dr. Ram Mohan Venepally, MD
Dr. Ram Mohan Venepally, MD is a Hospitalist healthcare provider based in Presque Isle, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033368113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ram Mohan Venepally, MD has received a total of $446.71 in payments from pharmaceutical and medical device companies, with $124.57 received in 2024. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($446.71).
As a Medicare-enrolled provider, Venepally has provided services to 1,875 Medicare beneficiaries, totaling 3,376 services with total Medicare billing of $258,959. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist
- Location Presque Isle, ME
- Active Since 09/15/2008
- Last Updated 09/10/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1033368113
Products in Payments
- CHANTIX (Drug) $110.28
- Impella (Device) $87.92
- Otezla (Drug) $68.95
- Trodelvy (Drug) $62.59
- PROMACTA (Drug) $32.38
- IMBRUVICA (Drug) $29.94
- Enhertu (Drug) $19.15
- LUMAKRAS (Drug) $18.00
- KEYTRUDA (Biological) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.